MDT Stock May Gain Following the Positive Data From Optimize PRO Study

Medtronic plc (MDT) recently announced new data for the Evolut Transcatheter Aortic Valve Replacement System (TAVR) at PCR London Valves 2024. This new clinical data gives implanters treating patients with symptomatic severe aortic stenosis additional insights.The latest Optimize PRO clinical research data showed positive clinical and procedural outcomes after Evolut valves were deployed using the cusp overlap technique and an improved care pathway. Furthermore, a pooled analysis of EvolutT PRO patients rev ...